ValiMed chosen for Geisinger Medical Center's Medication Safety Program

NewsGuard 100/100 Score

Worldwide studies show that high-risk medication compounding errors in pharmacies continue to cause significant harm to patients and economic loss to hospitals. Geisinger Medical Center joins a growing list of world-class hospitals that are proactively addressing this issue by selecting the ValiMed™ Medication Safety System to assure the "Right Drug at the Right Dose" every time. ValiMed is used to validate accurate compounding of high-risk medications and to reduce the diversion of return narcotics in healthcare facilities.

"After reading the University of Michigan Health System study that documented ValiMed's identification of five major medical mistakes over an 18 month period at one hospital, I knew that we needed to bring that technology in-house," said John Jones, Geisinger Vice President, System Therapeutics. "We purchased two ValiMed units to provide additional assurance of accuracy of our compounding practices."

"We are honored that Geisinger Medical Center selected ValiMed as part of its Medication Safety Program and look forward to working with John and his staff in integrating ValiMed into their daily practices," said Greg Firmbach, Senior Vice President of CDEX.

Source:

CDEX Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.